| Name | 2-(4-chloro-2-butenyl)-1,3-isoindolinedione |
|---|---|
| Synonyms |
trans-2-(4-chloro-2-butenyl)-1H-isoindole-1,3(2H)-dione
(E)-1-chloro-4-(N-phthalimido)-2-butene trans-1-chloro-4-phthalimido-2-butene N-[4-chloro(trans)-2-butenyl]phthalimide N-(4-chloro-2-butenyl)isoindole-1,3(2H)-dione (E)-2-(4-chloro-2-buten-1-yl)-1H-isoindole-1,3(2H)-dione TRANS-N-(4-CHLOROBUTENYL) PHTHALIMIDE |
| Molecular Formula | C12H10ClNO2 |
|---|---|
| Molecular Weight | 235.66600 |
| Exact Mass | 235.04000 |
| PSA | 37.38000 |
| LogP | 2.01550 |
|
~73%
49705-66-0 |
| Literature: Gov't of the USA as represented by The Secretary of the Department of Health and Human Services Patent: US2006/106030 A1, 2006 ; Location in patent: Page/Page column 4 ; US 20060106030 A1 |
|
~49%
49705-66-0 |
| Literature: Taiho Pharmaceutical Co. Ltd. Patent: US5401739 A1, 1995 ; |
|
~38%
49705-66-0 |
| Literature: PHARMACIA CORPORATION Patent: WO2005/25620 A2, 2005 ; Location in patent: Page/Page column 129 ; WO 2005/025620 A2 |
|
~%
49705-66-0 |
| Literature: Bojarski, Andrzej J.; Duszynska, Beata; Kolaczkowski, Marcin; Kowalski, Piotr; Kowalska, Teresa Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 23 p. 5863 - 5866 |